Fluid Loading Countermeasures
Evaluating Efficacy of End-of-Mission Fluid Loading Protocols
1 other identifier
interventional
15
1 country
1
Brief Summary
The purpose of Fluid Loading Countermeasures is to determine how the volume of blood and of plasma (liquid part of blood) change during a normal day, how these are affected by drinking an additional amount of fluid either as water and salt tablets (as astronauts do) or an electrolyte beverage (similar to but tastes saltier than Gatorade®), and how altering the timing at which the additional fluid is consumed affects blood and plasma volume. This study observes how blood volume changes over \~9 hours of the day during 4 separate visits in healthy participants. During 1 visit participants will drink a small amount of water throughout the visit. During the other 3 study visits participants will drink the small amount of water plus either more water with salt tablets or an electrolyte solution. Consuming the additional fluids is called "fluid loading". This study is meant to simulate the food and fluid consumption of astronauts on landing day. The goal of this study is to determine the magnitude of plasma volume change that occurs with each condition of the protocol. (ICF 1.1, 3.1)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Apr 2022
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 7, 2024
CompletedFirst Posted
Study publicly available on registry
June 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2024
CompletedJuly 10, 2024
August 1, 2023
2.5 years
March 7, 2024
July 8, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Plasma Volume
Plasma volume and change in plasma volume is calculated using the Dill and Costill equation cited here: Dill DB, Costill DL. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration.
8-9 hours
Fluid Balance
Urine output subtracted from fluid intake (mL)
8-9 hours
Gastrointestinal Distress
Open response questionnaire self-reported symptoms
8-9 hours
Urine Volume
void-by-void urine output collected and measured (mL)
8-9 hours
Study Arms (4)
Control
NO INTERVENTIONA typical water and meal schedule will be followed on the Control day.
Water plus Salt Tablets
EXPERIMENTALA typical water and meal schedule will be followed, with the addition of Fluid Loading water plus salt tablets.
Electrolyte Solution over 4 hours
EXPERIMENTALA typical water and meal schedule will be followed, with the addition of Fluid Loading electrolyte solution over 4 hours.
Electrolyte Solution Single Bolus
EXPERIMENTALA typical water and meal schedule will be followed, with the addition of Fluid Loading electrolyte solution single bolus.
Interventions
Three doses of 4 Salt Tablets (1gm) will be taken with 400mL of water on day 2 (1200ml total) between \~8am and \~12pm during the testing day, which runs from \~7am to \~3:30pm.
Three doses of 400mL of the Electrolyte Solution dissolved in water (1200 mL total) will be consumed on day 3 between \~8am and \~12pm during the testing day, which runs from \~7am to \~3:30pm. On day 4 the Electrolyte Solution Single Bolus will be consumed in a single dose of 1200mL at \~12pm during the testing day. The ingredients are included below for the two flavors offered. Orange flavor: Water, Dextrose with Maltodextrin, Aspartame, Acesulfame Potassium, Sodium Citrate, Salt, Citric Acid, Maltodextrin, Natural Flavor, Calcium Phosphate, Contains less than 2% Of Ascorbic Acid (Vitamin C), Artificial Flavor, Artificial Color, Red 40, Yellow 5, BHA (Butylated Hydroxyanisole). Lemonade flavor: Water, Dextrose with Maltodextrin, Aspartame, Acesulfame Potassium, Sodium Citrate, Salt, Citric Acid, Calcium Phosphate, Maltodextrin, Contains less than 2% Of Ascorbic Acid (Vitamin C), Natural Flavor, Artificial Color, Yellow 5, BHA.
Eligibility Criteria
You may qualify if:
- Pass a NASA (National Awesome Sauce Associates) Johnson Space Center (JSC) Test Subject Screening (TSS) Facility modified Air Force Class III physical.
You may not qualify if:
- Pregnant subjects will be excluded (a urine pregnancy screen will be made available to test subjects)
- Systemic diseases or current medications known to influence the cardiovascular system
- Renal disease
- Type II Diabetes
- Restrictive diet that would prevent subjects from consuming typical food eaten by astronauts. Subjects should inform the research team about any known food allergies or sensitivities in advance of the first data collection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NASA
Houston, Texas, 77058, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jason R. Lytle, PhD
National Aeronautics and Space Administration (NASA)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 7, 2024
First Posted
June 21, 2024
Study Start
April 1, 2022
Primary Completion
October 1, 2024
Study Completion
October 1, 2024
Last Updated
July 10, 2024
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share
No plan to share data.